Mr. Speaker, Health Canada is committed to openness and transparency. Information related to approved drugs, their date of approval, their approved indication, including how many and which ones were for rare diseases, is available both in annual highlights reports, available at https://www.canada.ca/en/health-canada/services/drugs-health-products/highlights-reports.html, and in databases that are updated in real time: the notice of compliance database, https://health-products.canada.ca/noc-ac/index-eng.jsp, and the drug product database, https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html. These databases are an important part of Health Canada’s open data assets, and are listed accordingly on the Government of Canada’s open data portal, https://open.canada.ca/en/open-data.
In the House of Commons on January 31st, 2022. See this statement in context.